Clinical trials
Dementia trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 14 |
| Terminated | 11 |
| Unknown status | 8 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| FORUM Pharmaceuticals Inc | 3 |
| Samsung Medical Center | 3 |
| Bristol-Myers Squibb | 2 |
| Chungnam National University | 2 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| TauRx Therapeutics Ltd | 2 |
| Washington University School of Medicine | 2 |
| Advanced Technology & Communications | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 49 |
| Alzheimer Disease | 37 |
| Brain Diseases | 14 |
| Cognitive Dysfunction | 14 |
| Neurodegenerative Diseases | 12 |
| Central Nervous System Diseases | 11 |
| Nervous System Diseases | 11 |
| Mental Disorders | 10 |
| Neurocognitive Disorders | 8 |
| Tauopathies | 8 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.